Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07609901 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Preventive Dendritic Cell Vaccination for Lynch Syndrome Carriers

Study acronym: PROTECT-Lynch
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The primary objective is to assess the effect of vaccination with neopeptide-loaded dendritic cells on disease-free survival (DFS) compared to placebo in LS subjects who are known to be carrier of a germline MMR-gene mutation with no signs of disease.
Trial Details
NCT Number NCT07609901
Lead Sponsor Radboud University Medical Center
Collaborators: Dutch National Health Care Institute
Conditions
(from sponsor)		 Lynch Syndrome
Related terms Colorectal Neoplasms, Hereditary Nonpolyposis
Enrollment 372 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov